Home - Products - Others - Other Targets - 2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine

2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine

CAS No. 237402-29-8

2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine( 2-[(1E)-(dibenzylhydrazin-1-ylidene)methyl]pyridine )

Catalog No. M28397 CAS No. 237402-29-8

2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine is a chemical compound.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 87 Get Quote
5MG 142 Get Quote
10MG 214 Get Quote
25MG 358 Get Quote
50MG 533 Get Quote
100MG 761 Get Quote
500MG 1557 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine
  • Note
    Research use only, not for human use.
  • Brief Description
    2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine is a chemical compound.
  • Description
    2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine is a chemical compound.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    2-[(1E)-(dibenzylhydrazin-1-ylidene)methyl]pyridine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    mGluR2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    237402-29-8
  • Formula Weight
    301.385
  • Molecular Formula
    C20H19N3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(N(Cc1ccccc1)\N=C\c1ccccn1)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mitul A Mehta, et al. Group II metabotropic glutamate receptor agonist prodrugs LY2979165 and LY2140023 attenuate the functional imaging response to ketamine in healthy subjects. Psychopharmacology (Berl). 2018 Jul;235(7):1875-1886.
molnova catalog
related products
  • Gemcitabine elaidate...

    Gemcitabine elaidate (CP-4126) hydrochloride is a lipophilic pro-drug of Gemcitabine, converted to Gemcitabine by esterases for phosphorylation.

  • MBC-11

    MBC-11 is a first-in-class conjugate of the bone-targeting bisphosphonate etidronate covalently linked to the antimetabolite cytarabine (araC), with potential to treat tumor-induced bone disease (TIBD).

  • GSK2850163 (S enanti...

    GSK2850163 (S enantiomer) is the inactive enantiomer of GSK2850163. GSK2850163 is an novel inhibitor of inositol-requiring enzyme-1 alpha (IRE1a).